Hematology

The CGTLive™ Hematology specialty topic page houses the most up-to-date clinical news coverage in the field of hematology gene and cell therapy. It also includes video interviews with key opinion leaders in the field of hematology/oncology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for various blood disorders.

Latest News

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – May 24, 2024

May 24th 2024

Review top news and interview highlights from the week ending May 24, 2024.

Evan Weber, PhD, an assistant professor of pediatrics at Children's Hospital of Philadelphia
Manipulation of the FOXO1 Gene Holds Potential to Enhance CAR T-Cell Fitness

May 23rd 2024

Around the Helix: Cell and Gene Therapy Company Updates – May 22, 2024
Around the Helix: Cell and Gene Therapy Company Updates – May 22, 2024

May 22nd 2024

Atara Submits BLA for Tab-Cel EBV+ PTLD T-Cell Therapy
Atara Submits BLA for Tab-Cel EBV+ PTLD T-Cell Therapy

May 21st 2024

Harish Venkatesh, BS candidate, Department of Regulatory and Quality Sciences, University of Southern California, Los Angeles, California
Cell and Gene Therapy Trials Face Disproportionate Amount of Clinical Holds

May 17th 2024

Video Interviews
Latest CME Events & Activities

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Patient, Provider, and Caregiver Connection™: Individualizing Care for Patients with Schizophrenia—Understanding Patient Challenges and the Role of Innovative Treatment

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Multiple Myeloma from the Summer Meetings

View More

Improving Outcomes in Autoimmune Hemolytic Anemias at the Intersection Between Hematology and Oncology Care

View More

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for Emerging E-Selectin Antagonists in the Management of AML

View More

Exploring Hot Topics in DLBCL: Sequencing CD19-Targeted Therapies, Strategies Post-CAR T Relapse, Novel Agents, and More!

View More

Do Patients with Multiple Myeloma Still Need Autologous Stem Cell Transplantation?

View More

8th Annual Live Medical Crossfire®: Hematologic Malignancies

July 20, 2024

Register Now!

Cancer Summaries and Commentaries™: Clinical Updates in MPNs from the Summer Meetings

View More

Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?

View More

Community Practice Connections™: Multidisciplinary Strategies for Improving Outcomes in CML from Frontline Care… and Beyond!

View More

B-Cell Tumor Board: Rendering Real World Personalized Treatment Plans in CLL/SLL and MCL Through the Lens of Emerging BTKi Evidence

View More

Myeloma Management Considerations: Applying the Evidence With Monoclonal Antibody Based Regimens

View More

Crucial Conversations in R/R Multiple Myeloma: Nursing Strategies to Optimize Patient Communication and Improve Outcomes

View More

Oncology Briefings™: Coordinating the Long-Term Management of Patients With Multiple Myeloma Between Primary Care and Oncology Practices

View More

GlobaOncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of B-Cell Lymphomas with BTK Inhibitors

View More

Community Practice Connections™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in AML

View More

Community Practice Connections: 7th Annual School of Nursing Oncology™

View More

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

October 18-19, 2024

Register Now!

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Oncology Consultations®: Community and Academic Perspectives on PNH Management – How Do You Do It?

View More

Community Oncology Connections™: Overcoming Clinical Challenges and Embracing New Opportunities in the Management of Multiple Myeloma

View More

Cases and Conversations™: Applying Guidelines to Practice for the Management of Paroxysmal Nocturnal Hemoglobinuria

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Oncology Briefings™: Selecting Therapy for Patients with Heavily Pretreated Myeloma Based on Patient and Disease-Specific Factors

View More

Medical Crossfire®: How Has the Nurse’s Role Evolved in the Management of Pediatric Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas?

View More

Community Practice Connections™: How Can We Optimize the Real World Application of BCMA-Targeted Therapies for Our Patients with R/R Multiple Myeloma?

View More

Oncology Briefings™: Case Discussions in Smoldering Myeloma—To Treat or Not to Treat?

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in CLL from San Diego

View More

Understanding the Recent Developments in Myelodysplastic Syndromes (MDS)

View More

More News

© 2024 MJH Life Sciences

All rights reserved.